Showing 301 - 320 results of 2,945 for search '"hepatitis"', query time: 0.06s Refine Results
  1. 301

    Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases by Brandon Yim, Elizabeth Kertowidjojo, Yue Zhang, Pruthvi Patel

    Published 2016-01-01
    “…Hepatic amyloidosis is a rare disease entity that results from insoluble amyloid protein deposition in the liver. …”
    Get full text
    Article
  2. 302
  3. 303

    Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy by Ying Peng, Qinglin Wei, Yun Liu, Zhenyu Wu, Hongjia Zhang, Hongbo Wu, Jin Chai

    Published 2021-01-01
    “…Background and Aims. Hepatic encephalopathy (HE) is characterized by recurrence and poor quality of life. …”
    Get full text
    Article
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313

    Budesonide in treatment of alcohol-induced severe hepatitis: results of randomized trial by I. I. Komkova, M. V. Mayevskaya, V. T. Ivashkin

    Published 2013-09-01
    Subjects: “…alcohol-induced hepatitis of severe course…”
    Get full text
    Article
  14. 314
  15. 315
  16. 316
  17. 317

    Isolated Avulsion of the Common Hepatic Duct from Blunt Abdominal Trauma by Victor W. Wong, Arvin Gee, Paul Hansen, Andrew Michaels

    Published 2012-01-01
    “…In this paper, we discuss a case of isolated avulsion of the hepatic duct confluence following blunt trauma that was successfully managed with Roux-en-Y hepaticojejunostomy. …”
    Get full text
    Article
  18. 318

    The Management of Chronic Viral Hepatitis: A Canadian Consensus Conference 2004 by Morris Sherman, Vincent Bain, Jean-Pierre Villeneuve, Robert P Myers, Curtis Cooper, Steven Martin, Catherine Lowe

    Published 2004-01-01
    “…The conference became necessary because of the introduction of new forms of therapy for both hepatitis B and hepatitis C. The conference issued recommendations on the investigation and management of chronic hepatitis B, including the use of lamivudine, adefovir and interferon. …”
    Get full text
    Article
  19. 319

    Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice by Sorim Choung, Kyong Hye Joung, Bo Ram You, Sang Ki Park, Hyun Jin Kim, Bon Jeong Ku

    Published 2018-01-01
    “…In addition, the HL group significantly decreased the hepatic expression of genes associated with lipid synthesis, cholesterol biosynthesis, and lipid droplet development and increased the hepatic expression of genes associated with fatty acid β-oxidation, thus suggesting that lobeglitazone decreased hepatic steatosis and reversed hepatic lipid dysregulation. …”
    Get full text
    Article
  20. 320

    Burden of Disease and Cost of Chronic Hepatitis C Virus Infection in Canada by Robert P Myers, Mel Krajden, Marc Bilodeau, Kelly Kaita, Paul Marotta, Kevork Peltekian, Alnoor Ramji, Chris Estes, Homie Razavi, Morris Sherman

    Published 2014-01-01
    “…BACKGROUND: Chronic infection with hepatitis C virus (HCV) is a major cause of cirrhosis, hepatocellular carcinoma and liver transplantation.…”
    Get full text
    Article